Response to "Comment on Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases"-论文-万方医学网

Response to "Comment on Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases"

导出原文传递

翻译打印收藏纠错

作者： Moran, Kellyn ^[1] ; Null, Kyle ^[2] ; Huang, Zhongwen ; Lissoos, Trevor ; Kane, Sunanda

作者单位： Takeda Pharmaceut USA Inc, US Med Affairs, Deerfield, IL USA ^[1] Mayo Clin, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA ^[2]

关键词 Inflammatory bowel disease IBD Intravenous biologics Oral small-molecule therapies

发布时间 2022-10-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Response to "Comment on Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases"

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Response to "Comment on Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases"

相似文献

相关期刊

检索历史清除